オプションチェーンは、Prudentialの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Prudentialの市場センチメントを評価します。.

Prudential (NYSE:PUK) 株価情報, オプションチェーン

Prudential

Originally established as Prudential Mutual Assurance, Investment, and Loan Association in 1848, Prudential plc has moved on a lot since then. Set up to sell life insurance and loans to the middle and then the industrializing and urbanizing working classes, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life in around 1985. During its time as owner of Jackson, Prudential focused on building out a simple chassis-style product portfolio where customers could choose a variety of add-ons. The company also became renowned for its focus on building requisite internal capabilities to support its strong product offerings, including compelling technology and a large and well-trained salesforce.

Prudential Public Limited Company Common Stock

Prudential PLC

PROVIDENCE RESOURCES INC by Providence Resources, Inc.

Pukang Group Holdings Ltd

WIIM

ARCC

BRDG

COIN

CRBG

GSIW

HLNE

HOOD

IBKR

Janus Henderson Group plc Ordinary Shares

LPLA

LPRO

OBDC

OXBR

PIPR

PRAA

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

QFIN

SHF Holdings, Inc. - Class A Common Stock

SHFS

SOFI

STEP

UPST

VCTR

Shares of companies within the broader financial sector are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods.

CACC

DBRG

DGICB

FSEA

HBAN

ITUB

LMND

NAVI

NEWT

NTRS

NYMT

PBHC

SLQD

TREE

TROW

WRLD

Shares of financial companies are trading higher amid overall market strength after President Trump said he will not be firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be lower than the current one, which may lead to greater business and lending activity for financial institutions.

CNFR

SLQT

Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.

AGNC

BANC

BXMT

BXSL

COLB

FULT

FUTU

GGAL

Hannon Armstrong Sustainable Infrastructure Capital

HASI

INTR

MUFG

SMFG

STWD

Shares of companies in the broader financial services sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ENVA

FRHC

SNEX

SPGI

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

PMAX

ZBAO

Shares of companies within the broader financial sector are trading lower in response to President Trump's sweeping Liberation tariffs and retaliatory responses. The sector is now facing greater macroeconomic uncertainty and recession fears.

ALLY

ATLC

Brighthouse Financial, Inc. - Common Stock

FTFT

KINS

KSPI

ROOT

Shares of companies within the broader financials sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

<h3>Companies Reporting Before The Bell</h3>
• Corporacion America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAAP#NYSE">CAAP</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $373.00 million. 
• Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) is likely to report quarterly earnings at $1.19 per share on revenue of $674.52 million. 
• Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $294.60 million. 
• GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is estimated to report quarterly loss at $0.27 per share on revenue of $430.70 million. 
• MediWound (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) is estimated to report quarterly loss at $0.61 per share on revenue of $5.75 million. 
• Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) is expected to report quarterly earnings at $6.25 per share on revenue of $2.33 billion. 
• J.Jill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JILL#NYSE">JILL</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $142.33 million. 
• Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $4.60 million. 
• Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) is projected to report quarterly loss at $0.11 per share on revenue of $269.59 million. 
• American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is estimated to report earnings for its fourth quarter. 
• Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $747.94 million. 
• Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) is projected to report quarterly earnings at $2.93 per share on revenue of $2.35 billion. 
• General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $4.96 billion. 
• One Stop Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>) is likely to report quarterly earnings at $0.01 per share on revenue of $15.00 million. 
• Direxion Daily CSI China Internet Index Bull 2X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEB#NYSE">CWEB</a>) is estimated to report earnings for its fourth quarter. 
• HUTCHMED (China) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) is expected to report earnings for its Fiscal Year 2024. 
<h3>Companies Reporting After The Bell</h3>
• Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) is projected to report quarterly earnings at $3.38 per share on revenue of $1.38 billion. 
• Epsilon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSN#NASDAQ">EPSN</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $7.22 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is likely to report earnings for its fourth quarter. 
• TWFG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWFG#NASDAQ">TWFG</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $47.78 million. 
• Precigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $1.30 million. 
• SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) is expected to report quarterly earnings at $1.01 per share on revenue of $9.70 million. 
• scPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPH#NASDAQ">SCPH</a>) is projected to report quarterly loss at $0.39 per share on revenue of $12.18 million. 
• CVD Equipment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVV#NASDAQ">CVV</a>) is likely to report earnings for its fourth quarter. 
• Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $8.89 million. 
• JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $559.67 million. 
• Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) is estimated to report quarterly loss at $0.41 per share on revenue of $3.88 million. 
• icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $4.50 million. 
• Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $9.87 million. 
• Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) is projected to report quarterly loss at $0.24 per share on revenue of $15 thousand. 
• LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) is estimated to report earnings for its fourth quarter. 
• North American (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOA#NYSE">NOA</a>) is estimated to report quarterly earnings at $1.17 per share on revenue of $318.60 million. 
• Aeva Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) is likely to report quarterly loss at $0.58 per share on revenue of $2.47 million. 
• Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $732.00 million. 
• Prudential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) is expected to report earnings for its Fiscal Year 2024. 
• Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $4.94 million. 
• FrontView REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVR#NYSE">FVR</a>) is expected to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AEVA

CAAP

CAPR

CWEB

EPSN

FIVE

GROY

ICAD

JILL

LENZ

LQDA

MDWD

OLLI

PGEN

PRSO

SCPH

SERA

SRAD

SWKH

TISI

TWFG

Earnings Scheduled For March 19, 2025

As of March 10, 2025, three stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>&lt;/a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.  
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Jack Henry &amp; Associates Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>)</h3>
<ul>
<li>On Feb. 4, Jack Henry &amp; Associates posted in-line quarterly earnings. According to Greg Adelson, President and CEO, &#8220;We are pleased to report solid performance in the second quarter of our fiscal year. We continued our positive sales momentum with record sales attainment in Q2 for the second consecutive year while maintaining a robust sales pipeline for future opportunities.&#8221; The company's stock gained around 10% over the past five days and has a <a href="https://www.benzinga.com/quote/JKHY">52-week high of $193.02</a>.</li>
<li>RSI Value: 77.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>JKHY Price Action: Shares of Jack Henry &amp; Associates gained 4.2% to close at $191.28 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Dynex Capital Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>)</h3>
<ul>
<li>On Feb. 20, Dynex Capital increased its monthly dividend from 15 cents to 17 cents. The company's stock gained around 8% over the past month and<a href="https://www.benzinga.com/quote/DX"> has a 52-week high </a>of $14.46.</li>
<li>RSI Value: 72.2</li>
<li>DX Price Action: Shares of Dynex Capital gained 2.5% to close at $14.37 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Prudential PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>)</h3>
<ul>
<li>On June 24, 2024, Prudential launched a share buyback program worth $2 billion. The company expects to complete the share buyback no later than mid-2026. CEO Anil Wadhwani, said, "Progress towards our financial objectives will increase the potential for further cash returns to shareholders. Our dividend policy remains unchanged, with the Board continuing to expect the 2024 annual dividend to grow in the range of 7-9 per cent." The company's stock gained around 16% over the past month and has a <a href="https://www.benzinga.com/quote/PUK">52-week high </a>of $21.27.</li>
<li>RSI Value: 71</li>
<li>PUK Price Action: Shares of Prudential gained 2.2% to close at $19.64 on Friday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

JKHY

Top 3 Financial Stocks That May Fall Off A Cliff In March

U.S. stocks were lower, with the Dow Jones index falling around 350 points on Wednesday.
Shares of Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) rose sharply during Wednesday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS <a href="https://in.benzinga.com/general/health-care/25/02/43643001/gilead-sciences-shares-push-higher-after-q4-report-heres-why">guidance above estimates</a>.
Gilead Sciences reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.70. Quarterly revenue came in at $7.56 billion which beat the analyst consensus estimate of $7.13 billion and is an increase over revenue of $7.11 billion from the same period last year.
Gilead Sciences shares jumped 8.1% to $103.88 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares jumped 30.7% to $88.07 after the company reported better-than-expected fourth-quarter financial results and issued FY25 revenue guidance above estimates. Multiple analysts upgraded the stock following the report.</li>
<li>AnaptysBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) rose 19.6% to $14.82 after the company announced statistically significant week 12 data from the Phase 2b trial of rosnilimab in moderate-to-severe rheumatoid arthritis.</li>
<li>Mercury General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCY#NYSE">MCY</a>) gained 17.4% to $58.80 after the company reported quarterly financial results. Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $70 to $80.</li>
<li>EHang Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>) rose 16.5% to $24.13.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) gained 15.5% to $34.78 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Angi Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) surged 15% to $1.9850 following better-than-expected fourth-quarter sales and a year-over-year increase in EPS results.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) climbed 14.6% to $63.05 after the company reported quarterly earnings and revenue above estimates.</li>
<li>Calumet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) gained 13.3% to $18.00.</li>
<li>The Chefs&#8217; Warehouse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>) gained 11.3% to $60.69 following better-than-expected quarterly reported financial results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) surged 9.2% to $28.05 following a fourth-quarter adjusted EPS and revenue beat.</li>
<li>iQIYI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) gained 9.2% to $2.50.</li>
<li>VNET Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) rose 8.5% to $10.82.</li>
<li>CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) gained 8.4% to $42.95  after the company reported better-than-expected quarterly financial results and Barclays raised its price target on the stock from $55 to $56.</li>
<li>Prudential plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) gained 6.1% to $18.10.</li>
<li>IAC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) surged 5.6% to $43.31 following strong quarterly sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43658834/this-ppg-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday">This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday</a></li>
</ul>

Intraday Update

Movers

ANAB

ANGI

CFLT

CHEF

CLMT

CRSP

GILD

VNET

Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday

CINF

ERIE

HRTG

Shares of insurance stocks are trading lower amid California wildfires.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Shares of health insurers are trading lower in sympathy with UnitedHealth, which reported Q3 financial results and lowered the upper end range of annual EPS outlook.

ALTI

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

Prudential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) reported quarterly earnings of $0.04 per share. This is a 87.25 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $4.96 billion in sales this quarter. This is a 8.06 percent increase over sales of $4.59 billion the same period last year.

Prudential H1 EPS $0.04 Down From $0.34 YoY, Sales $4.96B Up From $4.59B YoY

Prudential plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) shares are trading higher after the company launched a share buyback program worth $2 <a target="_blank" href="https://www.prudentialplc.com/en/news-and-insights/all-news/news-releases/2024/23-06-2024a" rel="noreferrer noopener">billion</a>.
The company expects to complete the share buyback no later than mid-2026.
CEO Anil Wadhwani, said, &#8220;Progress towards our financial objectives will increase the potential for further cash returns to shareholders. Our dividend policy remains unchanged, with the Board continuing to expect the 2024 annual dividend to grow in the range of 7-9 per cent.&#8221;
&#8220;Our outperformance in H1 2023 when the border between Hong Kong and the Chinese Mainland reopened results in a strong comparator for H1 2024. Q2 2024 APE sales trends are similar to those in Q1 2024.&#8221;
The terms of the proposed share buyback program will align with the shareholder approval obtained at the 2024 Annual General Meeting (AGM), and subsequently with any similar approval sought at the 2025 AGM.
Based on the current risk profile and applicable capital regulations across business units, the company aims to maintain a free surplus ratio between 175% and 200%. As of the end of 2023, Prudential&#8217;s free surplus ratio stood at 242%.
The company generated an operating free surplus generated from in-force insurance and <a target="_blank" href="https://www.benzinga.com//node/37852857" rel="noreferrer noopener">asset management business of&nbsp;$2.74 billion</a>.
Prudential plc anticipates releasing its half-year results for 2024 on <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">Wednesday, August 28, 2024</a>.
Price Action: PUK shares are up 7.97% at $19.45 at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Shutterstock/ bangoland

Equities

Large Cap

Buybacks

Prudential Pays Out: New $2B Stock Buyback Program Sweetens The Pot For Investors

Prudential shares are trading higher after the company announced a $2 billion buyback.

Shares of financial stocks are trading higher following a softer-than-expected May CPI Report. Also, the Fed left rates unchanged.

BBDO

BENF

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FIHL

RILY

TCJH

Shares of stocks within the broader financial sector are trading lower following earlier economic data. Also, the sector may be moving ahead of the upcoming Fed decision.

U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.
Shares of Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) fell sharply in today's pre-market trading after the company <a href="https://www.benzinga.com/quote/MED/earnings">reported mixed first-quarter financial results.</a>
Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Medifast shares tumbled 15.6% to $29.95 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>ADC Therapeutics SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NASDAQ">ADCT</a>) fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.</li>
<li>Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares declined 5.7% to $6.69 in pre-market trading.</li>
<li>Coeur Mining, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) shares fell 5.7% to $4.63 in pre-market trading.</li>
<li>Prudential plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>) slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Sibanye Stillwater Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) shares fell 5% to $4.82 in pre-market trading.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38510121/investor-sentiment-improves-further-dow-jumps-over-100-points">Investor Sentiment Improves Further, Dow Jumps Over 100 Points</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

ADCT

CHGG

COUR

MESO

RMBS

SBSW

YUMC

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Prudential plc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUK#NYSE">PUK</a>)&nbsp;shares are trading lower after the company&nbsp;<a target="_blank" href="https://www.prudentialplc.com/en/news-and-insights/all-news/news-releases/2024/20-03-2024" rel="noreferrer noopener">reported&nbsp;</a>FY 2023 results.
Insurance revenue was $9.371 billion versus $8.549 billion a year ago. New business profit rose 45% on CER basis (+43% AER basis) to $3.125 billion in the year.&nbsp;
Excluding interest rates and other economic movement effects, new business profit increased 47% Y/Y (+45% Y/Y) in the year.
Adjusted operating profit rose 8% (+6% Y/Y) to $2.893 billion. Operating free surplus generated from in-force insurance and asset management business stood at $2.74 billion (2022: $2.76 billion).
EPS was $0.619 versus a <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">loss of $(0.368) a year ago.</a>
The company declared second interim dividend of 14.21 cents per share and 20.47 cents per share for the full year, up 9% Y/Y.
Anil Wadhwani, CEO, said, &#8220;It has been six months since the launch of our new strategy and it&#8217;s highly encouraging to see the early progress on our strategic objectives of improving our customer experience, driving technology powered distribution and transforming our business model in Health.&#8221;
&#8220;We delivered an excellent financial and operational performance in 2023 and deployed increased levels of capital in new business, enhancing core capabilities and expanding distribution. Sales growth has continued in the first two months of 2024.&#8221;
Price Action: PUK shares are down 5.14% at $18.99 on the last check Wednesday.
Photo via Shutterstock

Comments

Prudential

Prudential (PUK) オプション

Prudential (NYSE:PUK) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル